Plain-English translation of NCT03253536 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that follows patients with hepatocellular carcinoma (a type of liver cancer) who receive stereotactic body radiation therapy (SBRT), a highly focused radiation treatment. Researchers want to understand how this treatment affects patients' quality of life—including physical, emotional, and social well-being—over time. You would receive the standard radiation treatment your doctors recommend, and researchers would simply measure your quality of life at regular intervals.
While stereotactic body radiation therapy is an established treatment option for liver cancer, doctors don't have detailed information about how it affects patients' day-to-day quality of life over the long term. This study aims to fill that gap by tracking real patients' experiences and well-being after treatment.
You likely qualify if…
You likely don't qualify if…
You would receive stereotactic body radiation therapy as your doctors normally would recommend—including planning scans and the actual treatment sessions. In addition to standard care, you would complete quality-of-life questionnaires at baseline (before treatment), at the end of treatment, and then at follow-up visits at 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years after treatment. These questionnaires take about 10–15 minutes to complete. The study lasts five years from your start date.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Germany
Sponsor
Ludwig-Maximilians - University of Munich
Enrollment target
~100 participants
Started
July 2017
Primary completion
July 2022
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2017.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Falk Roeder, MD
Department of Radiation Oncology, University Hospital, LMU Munich
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.